Loading...
Last update:  November 5, 2017
10:13 +1GMT

Allergenic Molecule  Hev b 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1400.71020130111, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013BrazilIgE1190.90020130429, Bueno de Sa A
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE993.03020110223, De Knop KJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012FranceIgE9724.00020120706, Garnier L
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
6.5 - Occupational Exposure2012South AfricaIgE850.00020120404, Singh T
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011TaiwanIgE1291.66020110119, Lee MF
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164080.34020100301, Scala E
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE1012.97020101118, Bublin M
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE865.81320101214, Gadisseur R
5.3.1 - Source Exposed (Symptoms, IgE)2010GermanyIgE5223.07020100423, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE482.08020101118, Bublin M
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE372.70220090826, Ebo DG
1.1 - Asymptomatic2009BelgiumIgE260.00020091121, Ebo DG
5.3.1 - Source Exposed (Symptoms, IgE)2009BelgiumIgE2218.18020091121, Ebo DG
3.2.1 - Source Sensitized (IgE)2009BelgiumBPT200.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE205.00020091005, Ott H
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanIgE140.00020090520, Yagami A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2009JapanSPT140.00020090520, Yagami A
3.2.1 - Source Sensitized (IgE)2009ItalyIgE70.00020091030, Quercia O
5.3.1 - Source Exposed (Symptoms, IgE)2008PortugalIgE50.00020080904, Rodrigues Alves R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2006SpainIgE2313.00020060324, Sanz ML
5.3.1 - Source Exposed (Symptoms, IgE)2005SpainIgE3154.800
3.1.2 - Source Sensitized - High Exposure (SPT)2003United StatesSPT6223.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2001GermanyIgE3881.600
3.1.4 - Source Sensitized (SPT, IgE)2001GermanyIgE1546.700
5.1.1 - Source Exposed (Symptoms)2000United StatesIgE4452.300
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000United StatesIgE280.0002000, Yeang HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000FinlandIgE813.0002000, Yeang HY
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1998FinlandIgE4238.100
6.6 - Source Exposure1997GermanyIgE14040.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1997GermanyIgE10552.400
5.2.1 - Source Exposed (Symptoms, SPT)1996FinlandIgE4517.800
6.6 - Source Exposure1995United StatesIgE1776.500
Developed by
Panservice